Revision

Lowe and Real Capital Solutions Acquire Westfield Mission Valley, 1.1-Million-Square-Foot Open Air Retail Center in San Diego

Retrieved on: 
Friday, July 21, 2023
Other Retail, Other Construction & Property, Retail, Commercial Building & Real Estate, Construction & Property, Nordstrom Rack, Partnership, Food, Housing, Buffalo Wild Wings, Marketing, Yard House, Revision, AMC, Accounting, Town and Country Shopping Center (Kettering), Target, Acquisition, Restaurant, IDEA1, Centennial, John Lowe (executive), Knowledge, Fitness, Environment, Country, Commercial property, Town, Westfield Mission Valley

Lowe and Real Capital Solutions announced today the acquisition of Westfield Mission Valley, an approximately 1.1-million-square-foot open air retail center which they intend to upgrade and reposition as a walkable, transit oriented mixed-use village.

Key Points: 
  • Lowe and Real Capital Solutions announced today the acquisition of Westfield Mission Valley, an approximately 1.1-million-square-foot open air retail center which they intend to upgrade and reposition as a walkable, transit oriented mixed-use village.
  • “Mission Valley center has a solid position in the market with many popular retailers and restaurants.
  • According to a recent survey, the Mission Valley center had approximately 9.8 million visitors over a 12-month period.
  • Centennial will provide a full spectrum of management services for the Mission Valley center, including property management, marketing and accounting.

Affordable housing, homelessness, and housing justice advocates issue joint statement urging revisitation of Governor's May Revise Budget Proposal

Retrieved on: 
Saturday, May 13, 2023
Housing, Legislature, Senate, Homelessness, Multimedia, New Markets Tax Credit Program, Revision, Administration, Portfolio, Assistance, Investment, Renewable energy, George House (California politician)

SACRAMENTO, Calif., May 12, 2023 /PRNewswire/ -- Our coalition of California's leading affordable housing, homelessness, and housing justice organizations, of which Housing California is a member, appreciate the Newsom administration's values-driven May Revision that maintains the critical housing and homelessness commitments from last year's budget.

Key Points: 
  • SACRAMENTO, Calif., May 12, 2023 /PRNewswire/ -- Our coalition of California's leading affordable housing, homelessness, and housing justice organizations, of which Housing California is a member, appreciate the Newsom administration's values-driven May Revision that maintains the critical housing and homelessness commitments from last year's budget.
  • The Revision articulates the Governor's continued commitment to the most pressing issues facing our state, including homelessness and housing affordability, and deference to sobering projections of an economic downturn.
  • These programs have a proven track-record of addressing housing affordability and homelessness across California.
  • The Senate Budget Plan builds on the Governor's proposal and would provide additional resources for key programs, including ongoing investment in homelessness and resources for key housing production programs.

Aequus Provides General Update and Fiscal 2022 Financial Results

Retrieved on: 
Tuesday, May 2, 2023
KOL, Travel, Revision, Eye, OTCQB, AQS, HCP, Novartis, Patient, CRM, Research, Health Canada, Fiscal, Ophthalmology

The higher loss was primarily due lower revenue in Fiscal 2022 relative to Fiscal 2021.

Key Points: 
  • The higher loss was primarily due lower revenue in Fiscal 2022 relative to Fiscal 2021.
  • Sales and marketing costs in Fiscal 2022 were $2,226,181 when compared to $2,173,592 in Fiscal 2021, a change of 2% or $52,589.
  • Research and development included product development expenses in Fiscal 2022 of $168,714 compared to $296,848 in Fiscal 2021, a decrease of 43% or $128,134.
  • General and administration expenses in Fiscal 2022 were $,1,593,362 compared to $2,023,773 in Fiscal 2021, a decrease of 21% or $430,411.

Medacta Group SA: Medacta Expands its Hip Offerings with New Cobalt-Free SensiTiN™ Double Mobility Converter

Retrieved on: 
Monday, November 7, 2022
Patient, Journal, Risk, Education, SAN, Titanium nitride, FDA, Systematic review, MD, Instability, Cobalt-chrome, Revision, Corrosion, Surgeon, Alloy, Dislocation, DM, Medical device, EU

Instability is still a major challenge and a significant issue for both primary and revision total hip arthroplasties, but Double Mobility (DM) devices can provide a viable solution.

Key Points: 
  • Instability is still a major challenge and a significant issue for both primary and revision total hip arthroplasties, but Double Mobility (DM) devices can provide a viable solution.
  • [4,5]
    The SensiTiN DM Converter is a cobalt-free, high-nitrogen-stainless steel modular DM device with an outer Titanium Nitride coating (SensiTiN), designed to improve corrosion resistance.
  • The SensiTiN DM Converter is available for both Medacta Primary and Revision multihole cup portfolios.
  • The SensiTiN DM Converter further completes and increases the versatility of Medacta's Acetabular Cup Portfolio for primary and revision total hip arthroplasties.

Revision Skincare® Announces Strategic Partnership with RVL Pharmaceuticals plc

Retrieved on: 
Tuesday, August 30, 2022
Cardiovascular disease, Ptosis, Partnership, Blepharoplasty, Focal neurologic signs, CEO, Eye injury, Research, Ophthalmoparesis, Horner's syndrome, Duane syndrome, Solution, Peptide, Glaucoma, Mark (given name), Revision, Orthostatic hypotension, Skin, Orbit, Headache, Xanthine oxidase inhibitor, GLOBE, Patient, Nasdaq, FDA, Stroke, Blood pressure, Hypertension, Hypotension, Risk, Aneurysm, Glycosidic bond, RVL, Eye, Industry, Metabolism, Myasthenia gravis, Marketing, Pharmaceutical industry, Phosphorus

DALLAS and BRIDGEWATER, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Revision Skincare, a leading medical-grade professional skincare brand, announced today a partnership with RVL Pharmaceuticals plc (Nasdaq: RVLP) (RVL), the owner of UPNEEQ, the first and only FDA-approved prescription eye drop for the treatment of acquired ptosis (low-lying lids) in adults.

Key Points: 
  • DALLAS and BRIDGEWATER, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Revision Skincare, a leading medical-grade professional skincare brand, announced today a partnership with RVL Pharmaceuticals plc (Nasdaq: RVLP) (RVL), the owner of UPNEEQ, the first and only FDA-approved prescription eye drop for the treatment of acquired ptosis (low-lying lids) in adults.
  • This strategic partnership pairs two unique disruptors within the aesthetics and skincare industries, both focused on providing patients with high-quality results.
  • We are excited to join this mission with RVL to offer breakthrough patient solutions, said Maria Carell, CEO and President of Revision Skincare.
  • Through the partnership, Revision Skincare and RVL Pharmaceuticals will bring broader access to revolutionary innovations like DEJ Eye Cream, Revox Line Relaxer, and UPNEEQ.

Exactech Celebrates 15 Years of Clinical Use: Equinoxe® Reverse Shoulder

Retrieved on: 
Thursday, March 31, 2022
General Health, Health, Surgery, Medical Devices, Complication, LinkedIn, SR, Active, Strathcona County, Revision, Comparison, Rotation, Percussion section, Risk, Hospital, Humerus, Motion, Inertia, Patient, Loss, Improvement, Roche, View, MD, Twitter, Collection, Clinic, Surgeon, Schoch, Machine learning, Great scapular notch, Physician, Science, Solution, YouTube, Systematic review, Instagram, Arthropathy, Birth control, Medical device, Wood drying, Silviculture, Équinoxe, Pacific Ocean, Extremities

View the full release here: https://www.businesswire.com/news/home/20220331005409/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220331005409/en/
    Exactech Celebrates 15 Years of Clinical Use: Equinoxe Reverse Shoulder (Graphic: Business Wire)
    One of the first systems to utilize a platform humeral stem, the Equinoxe reverse builds off all of the Equinoxe humeral stems, providing intraoperative flexibility and enabling surgeons to convert a well-fixed stem to a reverse without stem removal.
  • Impact of Inferior Glenoid Tilt, Humeral Retroversion and Bone Grafting on Muscle Length and Deltoid Wrapping in Reverse Shoulder Arthroplasty.
  • Comparison of survivorship and performance of a platform shoulder system in anatomic and reverse total shoulder arthroplasty.
  • ExactechGPS, Equinoxe Planning App and Predict+ are developed by Blue Ortho, an Exactech subsidiary, and distributed by Exactech, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220331005409/en/

Global Knee Implants Market (2022 to 2027) - by Replacement Type, Material, Fixation Approach and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 3, 2022
Nursing, Health, Chemicals, Plastics, Medical Devices, Surgery, Manufacturing, Managed Care, Partial, Ceramic, Industry, Revision, Value, Complex metallic alloys, Plastic, Cementation, Medical device, Shipbuilding, Material

The report analyses the Knee Implants Market by Type (Total Replacement, Partial Replacement and Revision Replacement)

Key Points: 
  • The report analyses the Knee Implants Market by Type (Total Replacement, Partial Replacement and Revision Replacement)
    The report analyses the Knee Implants Market by Material (Metal Alloys, Ceramics and Plastics)
    The report analyses the Knee Implants Market by Fixation Approach (Cemented, Cementless and Hybrid)
    The Global Knee Implants Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA)
    The Global Knee Implants Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Spain, China, Japan, India and Australia)
    The attractiveness of the market has been presented by region, by Type, by Material and Fixation Approach
    Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.
  • 4.1 Global Knee Implants Market Size, By Value, Year 2017-2027
    5.
  • Global Knee Implants Market Segmentation - By Type, By Material, Fixation Approach
    7.
  • Asia Pacific Knee Implants Market Segmentation (By Type, By Material, By Fixation Approach)

Aequus Reports Third Quarter 2021 Financial Highlights

Retrieved on: 
Wednesday, November 3, 2021
Lifting, Coronavirus, Technology, Q3, Perception, Patient, SEDAR, Revision, Health Canada, Consultant, Risk, OTCQB, Evolve, Forward-looking statement, Marketing, Company, Investment, Transplant, AQS, CEO, YTD, Tacrolimus, Acquisition, G&A, Therapy, Sabre Corporate Team Development, Ophthalmology, GLOBE, Legislation, Pharmaceutical industry

VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the quarter ended September 30, 2021 (Third Quarter 2021) and associated Company developments.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the quarter ended September 30, 2021 (Third Quarter 2021) and associated Company developments.
  • Aequus overall gross revenue grew 9% in the Third Quarter compared to Q2, and grew 15% compared to the same quarter last year.
  • Aequus reported its second highest revenue quarter to date, with $712,036 in revenue during Third Quarter 2021 compared to revenue of $618,984 generated during the same period in 2020.
  • Highlights from the quarter are as follows:
    Sales and marketing expenses for Third Quarter 2021 were $551,966 compared to $292,343 in Third Quarter 2020, an increase of $259,623.

Summit Ridge Energy breaks ground on 44MW Maine portfolio acquisition from Revision Energy

Retrieved on: 
Tuesday, October 12, 2021
Twitter, Revision, B Corporation (certification), Multimedia, LinkedIn, Hospital, Business development, Partnership, SRE, Solar energy, Renewable energy

ARLINGTON, Va., Oct. 12, 2021 /PRNewswire/ -- Summit Ridge Energy (SRE) has begun construction in Maine on the first of 13 projects acquired from Revision Energy. The community solar portfolio will total 44MW and operate under the Maine NEB program. The projects are expected to reach commercial operation between 2022 and 2023. SRE is the largest community solar owner-operator in the country with over $700mm in capital funded, holding the market share of projects in Maine and Illinois.

Key Points: 
  • ARLINGTON, Va., Oct. 12, 2021 /PRNewswire/ -- Summit Ridge Energy (SRE) has begun construction in Maine on the first of 13 projects acquired from Revision Energy.
  • The community solar portfolio will total 44MW and operate under the Maine NEB program.
  • Through its dedicated funding platform with Osaka Gas USA, SRE will finance the projects while Revision handles development, subscription, and construction of the portfolio.
  • Follow Summit Ridge Energy on LinkedIn and Twitter for updates, or learn more at srenergy.com .

Interstate Connecting Components (ICC) Introduces BHA PTFE-Plated M28876 Connectors from Amphenol Fiber Systems

Retrieved on: 
Monday, September 20, 2021
ICC, PTFE, COTS, Revision, BHA, Printed circuit board

LUMBERTON, N.J., Sept. 20, 2021 /PRNewswire-PRWeb/ -- Interstate Connecting Components , a division of Heilind Mil-Aero and leading distributor of military-aerospace connectors and accessories, is now offering M28876 circular fiber optic connectors with black hard anodized (BHA) PTFE (polytetrafluoroethylene) plating.

Key Points: 
  • LUMBERTON, N.J., Sept. 20, 2021 /PRNewswire-PRWeb/ -- Interstate Connecting Components , a division of Heilind Mil-Aero and leading distributor of military-aerospace connectors and accessories, is now offering M28876 circular fiber optic connectors with black hard anodized (BHA) PTFE (polytetrafluoroethylene) plating.
  • The connectors are precision-engineered by Amphenol Fiber Systems International, a leading manufacturer of fiber optic connectivity products.
  • Amphenol Fiber Systems' M28876 connectors operate with all qualified single mode and multimode M29504/14 and /15 termini.
  • Amphenol Fiber Systems International is a full-service fiber optic company specializing in the fabrication and manufacturing of fiber optic connectivity products and systems.